AzTrials
AzTrials

RadiculopathyPOLDAROSNCT00440856

Presentation of Lumbar Disc and Reduction of Symptoms

A study testing Presentation of excised intervertebral disc fragments in people with Radiculopathy, run by St George's, University of London at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The trial aims to assess the hypothesis that presentation of the disc material to the patient following a lumbar microdiscectomy would positively influence the improvement in their leg and back symptoms. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Radiculopathy
What is being tested?
Presentation of excised intervertebral disc fragments
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteUnited Kingdom
Study dates
Feb 2007to May 2008
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All adult patients undergoing a planned lumbar microdiscectomy for radiculopathy due to a prolapsed intervertebral disc

Who cannot join

  • inability to give verbal consent, age less than 18, previous spinal surgery, emergency discectomies, patients having spinal fusions and those with no radiculopathic symptoms.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • St George's Hospital, University of London

    London, London, SW17 0RE

Other trials in United Kingdom

About this study

Official title: Reduction in Leg and Back Pain Following Lumbar Microdiscetomy in Those Shown the Removed Disc Fragments After the Operation: a Double Blind Randomized Control Trial.

The trial aims to assess the hypothesis that presentation of the disc material to the patient following a lumbar microdiscectomy would positively influence the improvement in their leg and back symptoms.

Read the detailed description

Objective. The trial aims to assess the hypothesis that presentation of removed material to the patient following a lumbar microdiscectomy would positively influence the improvement in their radiculopathic and degenerative symptoms.

Design. Data will be collected prospectively. Patient allocation to treatment groups will be by simple randomization using a computer generated sequence of random numbers. Trial participants will be blinded as to the trial hypothesis and investigators blinded to patient allocation.

Setting. Patients will all be treated in a single secondary care unit.

Participants. All adult patients undergoing a planned lumbar microdiscectomy for radiculopathy due to a prolapsed intervertebral disc over a six month period will be considered for entry into the trial. Exclusion criteria: inability to give verbal consent, age less than 18, previous spinal surgery, emergency discectomies, patients having spinal fusions and those with no radiculopathic symptoms.

Intervention. Patients allocated to the experimental arm will be given the removed disc fragments to keep once they have recovered from anaesthesia. Those in the control arm will not be shown disc fragments (best available treatment).

Main outcome measure. The degree of improvement in radiculopathic and degenerative symptoms reported by the patient at 2-3 months after surgery.

Conditions
Radiculopathy
Being tested
Presentation of excised intervertebral disc fragments
Keywords
Intervertebral disc, Lumbar discectomy, Outcome, Radiculopathy due to prolapsed intervertebral disc.
Medical subject headings
Radiculopathy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Presentation of excised intervertebral disc fragmentsBehavioural

Study groups in NCT00440856
Study groupRoleWhat they receive
ControlNo interventionNot described
experimentalExperimentalParticipants are given their disc fragments following their operation
Receives: Behavioral: Presentation of excised intervertebral disc fragments

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective experience of radiculopathic pain by the patient following surgery

    Measured: 2-4 months

Secondary outcomes (6)
  1. Subjective experience of low back pain by the patient following surgery

    Measured: 2-4 months

  2. Subjective experience of lower limb motor weakness by the patient following surgery

    Measured: 2-4 months

  3. Subjective experience of paraesthesia by the patient following surgery

    Measured: 2-4 months

  4. Maximum walking distance

    Measured: 2-4 months

  5. Altered pattern of use of analgesia

    Measured: 2-4 months

  6. Subjective experience of numbness by the patient following surgery

    Measured: 2-4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Feb 2007 (estimated)
  2. Study startFeb 2007
  3. Primary completionApr 2008
  4. Study completionMay 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00440856
Sponsor's protocol ID
DT2656
Acronym
POLDAROS
Status last verified
May 2008
First submitted
23 Feb 2007
Last updated
9 Jun 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Presentation of excised intervertebral disc fragments in people with Radiculopathy, run by St George's, University of London at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective experience of radiculopathic pain by the patient following surgery (time frame: 2-4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in